Head-to-head · Cost-Efficiency Index
Goldspan Health vs Andrew Meds
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Goldspan Health
Shoppers who want a sublingual route priced openly beside the injection and who will count 13 charges a year rather than 12.
Visit Goldspan HealthAndrew Meds
Shoppers comparing published monthly rates who are willing to check that the price on the page is the price the checkout charges.
Visit Andrew MedsThe verdict
Goldspan Health takes it, leading the Cost-Efficiency Index 71 to 70. Goldspan Health sells compounded semaglutide at $229 and tirzepatide at $299 every 28 days, with daily sublingual and low-dose versions of both at lower prices, through a storefront operated by a different company. Andrew Meds still earns a C — Shoppers comparing published monthly rates who are willing to check that the price on the page is the price the checkout charges.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Goldspan Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Goldspan Health | Andrew Meds |
|---|---|---|
| Cost-Efficiency Index | 71/100 | 70/100 |
| Semaglutide / mo | $229 every 28 days month-to-month (13 charges a year, not 12) | $199/month month-to-month (the intake this page opens sells a $99 low-dose program instead) |
| Tirzepatide / mo | $299 every 28 days month-to-month (13 charges a year, not 12) | $299/month month-to-month |
| Semaglutide / yr (modeled) | $2,748 | $2,388 |
| Tirzepatide / yr (modeled) | $3,588 | $3,588 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #77 | #83 |
Goldspan Health
71/100Where the value is
- Prices ten separate GLP-1 products openly — injection and sublingual, standard and low dose, with a B12 or a glycine base — before any account
- Each plan card itemizes what the figure buys: the clinician evaluation, the medication, injection supplies, two-day shipping and clinical-team access
- States the billing cycle honestly on the plan card and the order timeline as 28 days and four weeks
The tradeoffs
- The hero prints "/month" over a plan billed every 28 days, which is 13 charges a year rather than 12
- "Pause, delay, or cancel at any time" sits against a refund policy reading "all sales are final" and storefront terms saying an order cannot be canceled once placed
Andrew Meds
70/100Where the value is
- Full month-to-month and prepay ladders for both molecules are printed on the product pages, before any intake
- States which pharmacy class fills a prescription — "a 503(A) compounding pharmacy or 503(B) outsourcing facility" — which most sellers at this price leave unsaid
- Names the prescribing practice, with a street address and a direct phone line, in the footer of every page
The tradeoffs
- Three live semaglutide prices disagree: $199 a month on the product page, $99 a month in the intake that page links to, and $149 for a four-week supply in a second funnel
- The tirzepatide page's own funnel offers only semaglutide, so the $299 tirzepatide price cannot be bought through the route the page provides
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.